HPV

New York Times reports on price cuts for HPV vaccine

Submitted by Sabin on Thu, 2013-05-09 09:12

Thanks to Pap tests, fatal cervical cancers are almost unknown today in rich countries. But the disease kills an estimated 275,000 women a year in poor countries where Pap tests are impractical and the vaccine is far too expensive for the average woman to afford, so the price cut could lead to a significant advance in women’s health.

Read more about New York Times reports on price cuts for HPV vaccine

HPV Burden in Latin America

Cervical cancer is one of the leading causes of cancer-related deaths among women in Latin America and the Caribbean. Of the 80,000 new cases and 36,000 cervical cancer deaths reported in the Americas each year, Latin American and Caribbean countries account for the vast majority.

In January 2007, Sabin joined forces with the Pan American Health Organization (PAHO) and the U.S. Centers for Disease Control and Prevention (CDC) to conduct a comprehensive study of HPV epidemiological data in Latin America, in an attempt to address this alarming global health concern.

Read more about HPV Burden in Latin America

Vaccine Advocacy & Education

The Vaccine Advocacy and Education program at Sabin is dedicated to reducing the burden of preventable diseases by bringing together key stakeholders and leaders in government, private sector and civil society in order to foster cooperation, share information and best practices, and develop improved vaccine policy and access.